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sistence. Following a recent report of an association of functional polymorphism of the serotonin transporter Genetic linkage and bipolar affective disorder:
transcriptional control region (5-HTTLPR), the authors progress and pitfalls conducted a study of 120 normal adult male and M Baron female volunteers. They found no relationship between the 5-HTTLPR polymorphism and any of the four TPQ Previous linkage studies of bipolar affective disorder (manic depression) can be described as a long search pesonality dimensions. These findings could not be explained by differences in genotype frequency or by with bouts of optimism and dashed expectations. In this review, the author revives new hope for elucidatethnic background (Ashkenazi and non-Ashkenazi).
Although lack of association in this study might be dising the etiology of this complex disorder. He reviews new findings of putative loci on chromosomes 18, 21, appointing, it is not an unexpected result of repeated investigations designed to confirm initial findings X, 4, 6, 13 and 15 as well as advances in genomics, statistical techniques, and clinical sample availability across diverse cultural and ethnic categories. which have all contributed to this author's renewed sense of optimism for the future prospect of identifying ORIGINAL RESEARCH ARTICLES and sequencing genes that predispose some to bipolar affective disorder.
Inhibition of the interleukin-1␤ converting enzyme family rescues neurons from apoptotic death T Lynch, JP Vasilakos, K Raser, KM Keane, PROGRESS

BD Shivers
Dissecting the genetic complexity of schizophrenia
Apoptosis is an active, genetically-controlled process M Karayiorgou, JA Gogos with an important role in the development of both the Schizophrenia is a complex and heterogeneous mental immune and nervous systems which can be triggered illness. In this integrative review, the authors discuss in pathological situations. The authors propose that some of the recent evidence and its place in determin-ICE (interleukin-1␤ converting enzyme) related proing the etiology of schizophrenia. Although twin, adopteases play an integral role in neuronal apoptosis tion and family studies have provided indirect eviwhich may contribute to neurological disorders and dence for a genetic contribution to the etiology of neurodegenerative diseases. In this study, they show schizophrenia, more recent studies which reveal many that the novel pan-ICE family inhibitor, boc-aspartyl highly polymorphic genetic markers seem to provide a (OMe)-fluoromethylketone (boc-Asp-Ch 2 F), protects more direct approach to the identification and localiz-CGN against apoptotic morphology and associated ation of schizophrenia susceptibility genes. Current DNA fragmentation. Naturally occurring programmed investigative efforts include linkage analysis, associcell death has been inhibited in vivo by the pharmacoation studies, search for chromosomal abnormalities, logical application of ICE inhibitors. These results have analysis of disorders with simple inheritance that overimplications for potential therapeutic interventions in lap phenotypically with schizophrenia and many brain disorders. more. Of the many leads that have been recently evaluated, the authors believe that each one brings us a step Association of polymorphisms of dopamine D 2 closer to elucidating the complexity of schizophrenia. addicted to heroin, were genotyped for the exon III repeat polymorphism in the dopamine D4 receptor.
Evidence of linkage between the serotonin
The long alleles were significantly over-represented in transporter and autistic disorder the opioid-dependent cohort. The long form of this EH Cook Jr, R Courchesne, C Lord, NJ Cox, S Yan, highly unusual polymorphism (chiefly represented by A Lincoln, R Haas, E Courchesne, BL Leventhal the 7 repeat allele), which contains multiple 16 amino acid repeats, has been previously shown to be associaPrevious research has indicated that genetic factors ted with Novelty Seeking, a human personality trait contribute to an individual's likelihood of developing characterized by impulsive and sensation-seeking autism. However, the genetics of autism are very combehavior. A number of studies have also shown that plex. It is probable that more than one gene plays a Novelty Seeking is prominent in substance abusers. causal role in this disorder. Therefore, it has been difThe conferred risk for substance abuse in the popuficult to discern which of the many genes might be lation group carrying the long forms of the allele is a important. The well-established finding that a signifimodest 2.46 which suggests that additional genes may cant number of people with autism have elevated leveventually be identified that also predispose to els of blood serotonin and the successful use of mediaddictive behavior in humans. cations (potent serotonin transporter inhibitors, PSTIs) that partially treat the rituals in autism led to the possibility that serotonin may play a role in autism. The
SEMINARS IN MOLECULAR PSYCHIATRY AT
PSTIs directly block a protein, the serotonin trans-THE CLINICAL NEUROENDOCRINOLOGY porter, in some nerve cells in the brain. Therefore, the BRANCH, NIMH, NIH authors studied 86 people with autism and their parPossible mechanisms for atrophy of the human ents to examine whether the gene for the serotonin hippocampus transporter may contribute to the risk for autism. In BS McEwen this process, they have found evidence that there is a significant relationship between autism and this gene.
The hippocampus is a brain structure responsible for This is not only the first gene to be linked to autism several modes of cognitive function, including differbut it is also consistent with long known information ent types of memory. It has long been known that the suggesting that abnormalities in serotonin functioning hippocampus is a target of stress hormones; this area may contribute to autism. If replicated by other is also an especially plastic and vulnerable region of researchers, this information may eventually contribthe brain. In this article, the author summarizes the ute to the development of improved diagnosis and research about the mechanism of hippocampal neumedical treatment of autism.
ronal atrophy in several animal models. He also discusses the relationship between reversible atrophy and permanent cell loss, including the possibility of theraExcess dopamine D4 receptor (D4DR) Exon III seven peutic strategies for reversing atrophy and preventing repeat allele in opioid-dependent subjects permanent damage. These strategies are of potential M Kotler, H Cohen, R Segman, I Gritsenko, relevance to depression and post-traumatic stress dis-L Nemanov, B Lerer, I Kramer, M Zero-Zion, I Kletz, order, which have both been associated with hippo-RP Ebstein campal atrophy. Both twin studies in humans and studies on the pharmacogenetics of opioid addiction in rodents point to a J Licinio, MD Editor role for heritability as a contributing factor in the
